Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Paceport Swan-Ganz Data Collection Study

NCT04782154 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.

NCT NCT04782154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04782154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Paceport Swan-Ganz Data Collection Study
Lead sponsor
Montreal Heart Institute
Phase
Observational
Overall status
Completed
Start date
August 9, 2021
Completion date
April 1, 2022
Enrollment
136 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure, right heart failure, right ventricular dysfunction